Abstract:We propose that neuroimmune factors, for example, genetic, early‐life trauma, infections, autoimmune diseases, and gut microbiota abnormalities, interact within each patient's life trajectory to determine the emergence of altered microglial states that we named bipolar disorder (BD)‐associated microglial states. We hypothesize that these microglial states pair the systemic immune‐inflammatory alterations present in patients with BD according to each disease phase (acute states vs. euthymia, early‐ vs. late‐stage) and are characterized by critical changes in structure and functions that are progressive along the disease timeline and marked by a loss in homeostatic functions, culminating into final dystrophic states similar to those observed in neurodegenerative conditions. Bipolar disorder (BD) is a severe and multifactorial disease, with onset usually in young adulthood, which follows a progressive course throughout life. Replicated epidemiological studies have suggested inflammatory mechanisms and neuroimmune risk factors as primary contributors to the onset and development of BD. While not all patients display overt markers of inflammation, significant evidence suggests that aberrant immune signaling contributes to all stages of the disease and seems to be mood phase dependent, likely explaining the heterogeneity of findings observed in this population. As the brain's immune cells, microglia orchestrate the brain's immune response and play a critical role in maintaining the brain's health across the lifespan. Microglia are also highly sensitive to environmental changes and respond to physiological and pathological events by adapting their functions, structure, and molecular expression. Recently, it has been highlighted that instead of a single population of cells, microglia comprise a heterogeneous community with specialized states adjusted according to the local molecular cues and intercellular interactions. Early evidence has highlighted the contribution of microglia to BD neuropathology, notably for severe outcomes, such as suicidality. However, the roles and diversity of microglial states in this disease are still largely undermined. This review brings an updated overview of current literature on the contribution of neuroimmune risk factors for the onset and progression of BD, the most prominent neuroimmune abnormalities (including biomarker, neuroimaging, ex vivo studies) and the most recent findings of microglial involvement in BD neuropathology. Combining these different shreds of evidence, we aim to propose a unifying hypothesis for BD pathophysiology centered on neuroimmune abnormalities and microglia. Also, we highlight the urgent need to apply novel multi‐system biology approaches to characterize the diversity of microglial states and functions involved in this enigmatic disorder, which can open bright perspectives for novel biomarkers and therapeutic discoveries.

Mitochondria at the crossroad of dysregulated inflammatory and metabolic processes in bipolar disorders

Mitochondrial Dysfunction as a Biomarker of Illness State in Bipolar Disorder: A Critical Review

Involvement of Kynurenine Metabolism in Bipolar Disorder: an Updated Review

Gut Microbial Clues to Bipolar Disorder: State‐of‐the‐art Review of Current Findings and Future Directions

Mitochondrial Dysfunction in the Pathophysiology of Bipolar Disorder: Effects of Pharmacotherapy

Mitochondria, Metabolism, and Redox Mechanisms in Psychiatric Disorders

Inflammation in Bipolar Disorder (BD): Identification of new therapeutic targets

Dysregulation of mitochondrial dynamics, mitophagy and apoptosis in major depressive disorder: Does inflammation play a role?

Targeting Inflammatory-Mitochondrial Response in Major Depression: Current Evidence and Further Challenges

The Role of Mitonuclear Incompatibility in Bipolar Disorder Susceptibility and Resilience Against Environmental Stressors

Insights into Major Depression as a Mitochondria-Associated Disease

Bipolar Disorder: Role of Immune-Inflammatory Cytokines, Oxidative and Nitrosative Stress and Tryptophan Catabolites

Mitochondria and Brain Disease: A Comprehensive Review of Pathological Mechanisms and Therapeutic Opportunities

Pathogenesis or a response to lithium? A novel perspective for mitochondrial mass fluctuation of naïve T cells in patients with bipolar disorder

A model of the mitochondrial basis of bipolar disorder

Unraveling the Link Between Mitochondrial Dynamics and Neuroinflammation

Non-canonical pathways in the pathophysiology and therapeutics of bipolar disorder

TSPO upregulation in bipolar disorder and concomitant downregulation of mitophagic proteins and NLRP3 inflammasome activation

Blood-brain barrier dysfunction in bipolar disorder: Molecular mechanisms and clinical implications

The emerging neuroimmune hypothesis of bipolar disorder: An updated overview of neuroimmune and microglial findings

Bipolar Disorder and Immune Dysfunction: Epidemiological Findings, Proposed Pathophysiology and Clinical Implications